Effects of phosphorus-restricted diet and phosphate-binding therapy on outcomes in patients with chronic kidney disease (Q39237776)

10 September 2017

title

Effects of phosphorus-restricted diet and phosphate-binding therapy on outcomes in patients with chronic kidney disease (English)

1 reference

10 September 2017

Domenico Russo

1

1 reference

10 September 2017

Antonio Bellasi

2

1 reference

10 September 2017

Andrea Pota

3

1 reference

10 September 2017

Luigi Russo

4

1 reference

10 September 2017

Biagio Di Iorio

5

1 reference

10 September 2017

publication date

6 March 2014

1 reference

10 September 2017

published in

Journal of Nephrology

1 reference

10 September 2017

volume

28

1 reference

10 September 2017

issue

1

1 reference

10 September 2017

page(s)

73-80

1 reference

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0071-2

Associates of mortality and hospitalization in hemodialysis: potentially actionable laboratory variables and vascular access

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0071-2

Phosphorus binders and survival on hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0071-2

Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0071-2

Relation between serum phosphate level and cardiovascular event rate in people with coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0071-2

Serum phosphate levels and mortality risk among people with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0071-2

Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0071-2

The mechanism of phosphorus as a cardiovascular risk factor in CKD

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0071-2

Phosphate metabolism in the setting of chronic kidney disease: significance and recommendations for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0071-2

The emerging role of phosphate in vascular calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0071-2

Serum phosphorus concentrations and arterial stiffness among individuals with normal kidney function to moderate kidney disease in MESA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0071-2

Serum phosphorus levels associate with coronary atherosclerosis in young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0071-2

Progression of coronary artery calcification and cardiac events in patients with chronic renal disease not receiving dialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0071-2

Progression of cardiac valve calcification and decline of renal function in CKD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0071-2

Influence of lipid-lowering therapy on the progression of coronary artery calcification: a prospective evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0071-2

Effects of phosphate binders in moderate CKD

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0071-2

Phosphate binders in moderate chronic kidney disease: where do we stand?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0071-2

Chronic kidney disease progression and outcome according to serum phosphorus in mild-to-moderate kidney dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0071-2

The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0071-2

Mortality in kidney disease patients treated with phosphate binders: a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0071-2

Progression of coronary artery calcification in predialysis patients

21 January 2018

1 reference

12 December 2020

K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease

1 reference

12 December 2020

Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study

1 reference

12 December 2020

Acute effects of very-low-protein diet on FGF23 levels: a randomized study

1 reference

12 December 2020

KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

1 reference

12 December 2020

Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP)

1 reference

12 December 2020

10.1007/S40620-014-0071-2

Identifiers

DOI

1 reference

release_wcgy6nefjzgqxlu6pjx2cm2dcu

10 September 2017

Fatcat ID

0 references

1 reference